3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
242
Completed
69
Recruiting
56
Not yet recruiting
32
Active not recruiting
17
Terminated
12
Withdrawn
9
Suspended
2
Enrolling by invitation
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Osteosarcoma
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Neoplasms
1
Interventions
Specimen Handling
32
Magnetic Resonance Spectroscopy
21
Biopsy
20
Cyclophosphamide
16
Nivolumab
10
Paclitaxel
9
Cisplatin
9
Gemcitabine
8
Bevacizumab
8
venetoclax
7
Vincristine
7
Prednisone
7
Doxorubicin
7
Azacitidine
7
pembrolizumab
6
Radiotherapy
6
Radiosurgery
6
Fluorouracil
6
Etoposide
6
Drug Therapy
6
Docetaxel
6
Taxes
5
Rituximab
5
Oxaliplatin
5
Irinotecan
5
Everolimus
5
Capecitabine
5
fludarabine phosphate
4
fludarabine
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Suspended
×
Interventional
×
apatinib
×
Clear all
NCT04824352
2024-05-14
AIEO
Peking University People's Hospital
Phase 2
Suspended
44 enrolled
NCT03743428
2023-06-29
BABST-C
Shenzhen People's Hospital
Phase NA
Suspended
40 enrolled